Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity

The poor outcome of advanced ovarian cancer under conventional therapy stimulated the exploration of new strategies to improve therapeutic efficacy. In our preclinical in vitro study we investigated a combination of targeted therapy and immunotherapy. Combination treatment with the anti-EGFR-antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottschalk, Nina, Kimmig, Rainer, Lang, Stephan, Singh, Mahavir, Brandau, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472788/
https://www.ncbi.nlm.nih.gov/pubmed/23109896
http://dx.doi.org/10.3390/ijms130912000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472788/
https://www.ncbi.nlm.nih.gov/pubmed/23109896
http://dx.doi.org/10.3390/ijms130912000

Ejemplares similares